ABOUT AMOUN

About Amoun Research and Development

An Amman-based pharmaceutical R&D company focused on generic drug product development — supporting partners with formulation, documentation, and dossier solutions.

ABOUT AMOUN

About Amoun Research and
Development

An Amman-based pharmaceutical R&D company focused on generic drug product development — supporting partners with formulation, documentation, and dossier solutions.

Our Mission

To support pharmaceutical companies with reliable generic product development, formulation, documentation, and dossier solutions — built on technical rigor and partner trust.

Generic R&D, end-to-end

From originator analysis to dossier-ready documentation, we cover the full development chain.

Our Process

Six structured stages from originator analysis to dossier collaboration.

01

Originator product analysis

Deep characterization of the reference product to define R&D targets.

02

Originator product analysis

Deep characterization of the reference product to define R&D targets.

03

Originator product analysis

Deep characterization of the reference product to define R&D targets.

04

Originator product analysis

Deep characterization of the reference product to define R&D targets.

05

Originator product analysis

Deep characterization of the reference product to define R&D targets.

06

Originator product analysis

Deep characterization of the reference product to define R&D targets.

Why Choose Amuon

Scientific R&D focus

Method-driven development grounded in pharmaceutical science.

Partner-focused approach

Transparent communication and shared technical ownership.

Generic product expertise

Deep know-how across solid dosage and semi-solid forms.

Flexible collaboration

Engagement models that fit each
partner's program

Growing portfolio

Expanding catalogue across multiple therapeutic segments.

Documentation support

Stability, BE-relevant documents and CTD-structured files.

Looking for a Pharmaceutical R&D
Partner?

Connect with Amoun to discuss generic product development, scale-up support, or dossier collaboration.

Document
Scroll to Top